Apolipoprotein B (Apo B)
Request package insert information
Product Features
The assay has a linear range of 3.6 – 242 mg/dL with good correlation with existing FDA approved product with r2 values >0.98. The Diazyme Apo B Assay is not interfered by the following substances at the indicated concentrations: triglycerides at 1000 mg/dL, ascorbic acid at 10 mM, bilirubin at 40 mg/dL, bilirubin conjugate at 40 mg/dL, and hemoglobin at 1000 mg/dL. The reagent is stable for 12 months from the date of manufacture when stored @ 2°-8°C.
Assay Principle
This method is based on the reaction of a sample containing human Apo B and a specific antiserum to form an insoluble complex which can be measured turbidimetrically at 340 nm. By constructing a standard curve from the absorbance of standards the concentration of apo B in the samples can be determined.
Intended use
The Diazyme Apolipoprotein B Assay is intended for the quantitative in vitro determination of apolipoprotein B (Apo B) in serum and plasma. It can be used as an aid for assessing the risk of coronary artery disease.
Product Catalog Number Packaging Method/Format
Kit (1120 Tests) DZ142A-K R1: 4 x 70 mL
R2: 2 x 50 mL
 Immunoturbidimetric
Liquid Stable
Calibrator DZ141A-Cal 1 x 1 mL  
Control DZ138A-Con 3 x 3 mL